Kazia concludes first stage of Phase I advanced cancer treatment trial [Yahoo! Finance]
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS [Yahoo! Finance]
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS
Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases [Yahoo! Finance]
Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases